Astera Labs, INC Form 4 insider transactions

Astera Labs General Counsel and Secretary, Philip Mazzara, reported the sale of company stock totaling over 10,000 shares through a pre-arranged trading plan.

Astera Labs CEO Jitendra Mohan sold 157,500 common shares for approximately $20.7 million through a pre-arranged 10b5-1 trading plan.

Astera Labs Director Jack R. Lazar reported a future sale of 2,500 shares of common stock for $130 per share under a pre-arranged 10b5-1 trading plan.

Astera Labs' General Counsel and Secretary, Philip Mazzara, sold 9,000 shares of common stock on March 2, 2026, through a pre-arranged 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold 94,971 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Astera Labs' President and COO, Sanjay Gajendra, sold 94,971 shares of common stock on February 17, 2026, to cover tax withholding obligations related to RSU vesting.

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 12,001 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Astera Labs' General Counsel, Philip Mazzara, sold 4,849 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Astera Labs' Chief Financial Officer, Michael Truett Tate, was granted 11,787 restricted stock units on February 6, 2026, under the company's 2024 incentive plan.

Astera Labs' President and COO, Sanjay Gajendra, received a grant of 26,522 restricted stock units, vesting over several years.

Astera Labs CEO Jitendra Mohan received an award of 26,522 restricted stock units, vesting over several years.

Astera Labs' General Counsel and Secretary, Philip Mazzara, was granted 5,893 restricted stock units under the company's 2024 Stock Option and Incentive Plan.

Astera Labs, Inc. granted restricted stock units to its Chief Accounting Officer and VP of Finance, Germaine Cota, as part of its 2024 Stock Option and Incentive Plan.

Astera Labs' General Counsel and Secretary, Philip Mazzara, sold 9,900 shares of common stock on January 2, 2026, through a pre-arranged 10b5-1 trading plan.

Astera Labs Director Manuel Alba reported the sale of 32,000 common shares on December 1, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs President and COO, Sanjay Gajendra, reported gifting a total of 142,000 shares of common stock to a non-affiliated entity over two days in December 2025.

Astera Labs Director Manuel Alba executed pre-planned sales of 150,000 common shares totaling approximately $24.9 million.

Astera Labs CEO Jitendra Mohan transferred 559,230 shares of common stock to a living trust for estate planning purposes.

Astera Labs Director Jack R. Lazar sold 2,300 shares of common stock on November 20, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold 90,459 shares of common stock on November 17, 2025, to cover tax withholding obligations from RSU vesting.

Astera Labs' General Counsel, Philip Mazzara, sold 4,620 shares of common stock on November 17, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 11,430 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Astera Labs President and COO, Sanjay Gajendra, sold 90,459 shares of common stock on November 17, 2025, to cover tax withholding obligations related to restricted stock unit vesting.

Astera Labs’ General Counsel Philip Mazzara acquired 87 common shares at $78.3615 under the 2024 ESPP, increasing direct holdings to 151,660 shares.

Astera Labs' General Counsel, Philip Mazzara, sold 10,000 shares of common stock on October 1, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs' Chief Financial Officer, Michael Truett Tate, reported a gift of 7,000 shares of common stock, effective September 11, 2025.

Astera Labs Director Manuel Alba sold 192,940 shares of common stock for approximately $31.8 million through pre-arranged 10b5-1 trading plans.

Astera Labs President and COO, Sanjay Gajendra, transferred 480,668 shares of common stock to an estate planning trust for no consideration.

Astera Labs' General Counsel, Philip Mazzara, plans to sell 10,000 shares of common stock for approximately $1.89 million on August 28, 2025, under a pre-arranged 10b5-1 trading plan.

Astera Labs Director Jack R Lazar sold 22,500 shares of common stock on August 27, 2025, under a pre-arranged 10b5-1 trading plan.